Sort
30,917 grants matching “tumor microenvironment”
Collagen remodeling and tumor progression
$345,339Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2013 · CA
Improvement of cellular immunotherapy during dysbiosis- Resubmission
$345,287Ruud P.m. Dings · Univ Of Arkansas For Med Scis · R01 · FY2021 · CA
Clinical Trail of Vaccine in Combination with Toll-Like Receptor (TLR)
$345,281Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA
Project 2: Sexual Dimorphism of Iron Metabolism in GBM
$345,280James R Connor · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · CA
Defining Early Escape Strategies in LKB1 Mutant Lung Cancer
$345,265Adam I Marcus · Emory University · R01 · FY2019 · CA
Conditional Knockout of Calcium Receptors in Bone Cells
$345,263Dolores M Shoback · Northern California Institute/Res/Edu · R01 · FY2010 · AR
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$345,260Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2022 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$345,230Ahmed Chadli · Augusta University · R01 · FY2023 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$345,230Ahmed Chadli · Augusta University · R01 · FY2022 · CA
Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
$345,230Hasan Korkaya · Augusta University · R01 · FY2022 · CA
Targeting the vasculature to enhance anti-tumor immunity
$345,206Andrew Carl Dudley · University Of Virginia · R01 · FY2024 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$345,184James A Wells · University Of California, San Francisco · R01 · FY2024 · CA
Neuronal activity-regulated mechanisms of glioma growth
$345,173Michelle Monje-Deisseroth · Stanford University · R01 · FY2020 · NS
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
$345,140Geoffrey L Uy · Washington University · P50 · FY2015 · CA
In vivo monitoring of tumor microenvironment regulation by macrophages
$345,118Valery V Khramtsov · West Virginia University · R01 · FY2017 · CA
CD38 Pretargeted Radioimmunotherapy for Myeloma
$345,117Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
Tumor models for the study of inflammation and oncogenesis
$345,081Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Modulation of inflammasome-mediated cytokine activation by EGCG in human melanoma.
$345,034Mayumi Fujita · University Of Colorado Denver · R01 · FY2019 · CA
Microenvironment-induced metabolic plasticity in leukemia stem cells
$345,034Craig T. Jordan · University Of Colorado Denver · R01 · FY2019 · CA
Mechanisms underlying pro-metastatic effects of estrogen in the brain niche
$345,034Diana M. Cittelly · University Of Colorado Denver · R37 · FY2019 · CA
Cancer-associated fibroblasts in estrogen receptor positive breast cancer.
$345,034Peter Kabos · University Of Colorado Denver · R01 · FY2019 · CA
Deciphering COX-2/SEMA7A dependent mechanisms of breast tumor progression.
$345,034Traci Lyons · University Of Colorado Denver · R01 · FY2019 · CA
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy
$345,034Maria L Avantaggiati · Georgetown University · R01 · FY2019 · CA
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
$345,034Joanna B Kitlinska · Georgetown University · R01 · FY2019 · CA
Neuronal activity-regulated mechanisms of glioma growth
$345,030Michelle Monje-Deisseroth · Stanford University · R01 · FY2019 · NS